Serum interleukin 40: an innovative diagnostic biomarker for patients with systemic lupus erythematosus.

No abstract is available for this paper.

• Publication year

  2023

• Venue

  The Medical journal of Malaysia

• Publication date

  2023-09-01

• Fields of study

  Medicine

• Identifiers
  PMID 37775487
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interleukin-40 is a promising biomarker associated with type 2 diabetes mellitus risk.

  2023cited by this paper
• POS0101 POTENTIAL INVOLVEMENT OF IL-40 AND IL-40 PRODUCING CELLS IN SYSTEMIC LUPUS ERYTHEMATOSUS AND LUPUS ASSOCIATED NEPHRITIS

  2022cited by this paper
• Evaluation of Interferon Alpha (IFN-α) in Women with Systemic Lupus Erythematosus in Iraq

  2022influential reference
• Diagnostic potential of interleukin-40 (IL-40) in rheumatoid arthritis patients

  2022cited by this paper
• The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics

  2021cited by this paper
• Deconvoluting the heterogeneity of SLE: The contribution of ancestry.

  2021cited by this paper
• IL-40: A New B Cell-Associated Cytokine Up-Regulated in Rheumatoid Arthritis Decreases Following the Rituximab Therapy and Correlates With Disease Activity, Autoantibodies, and NETosis

  2021cited by this paper
• Assessment of EULAR/ACR-2019, SLICC-2012 and ACR-1997 Classification Criteria in SLE with Longstanding Disease

  2021cited by this paper
• The Fascination of Cytokine Immunological Science

  2020cited by this paper
• Systemic Lupus Erythematosus Disease Activity Index

  2020cited by this paper
• Association between serum level of pentraxin-3 and interleukin-40 with HCC disease in Egypt

  2020cited by this paper
• 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

  2019cited by this paper
• SLE: reconciling heterogeneity

  2019cited by this paper
• Novel paradigms in systemic lupus erythematosus.

  2019cited by this paper
• Interleukin 30 to Interleukin 40

  2018cited by this paper
• The Incidence and Prevalence of Systemic Lupus Erythematosus in New York County (Manhattan), New York: The Manhattan Lupus Surveillance Program

  2017cited by this paper
• The Incidence and Prevalence of Systemic Lupus Erythematosus in San Francisco County, California: The California Lupus Surveillance Project

  2017cited by this paper
• Identification of IL-40, a Novel B Cell–Associated Cytokine

  2017cited by this paper
• Systemic lupus erythematosus biomarkers: the challenging quest

  2016cited by this paper
• Biomarkers in systemic lupus erythematosus: challenges and prospects for the future

  2013cited by this paper
• Identification of New Autoantigens by Protein Array Indicates a Role for IL4 Neutralization in Autoimmune Hepatitis*

  2012cited by this paper
• Biomarkers for systemic lupus erythematosus

  2012cited by this paper
• The geoepidemiology of systemic lupus erythematosus.

  2010cited by this paper
• High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus.

  2007cited by this paper
• Cytokine IL-6 and IL-10 as Biomarkers in Systemic Lupus Erythematosus

  2007cited by this paper
• Gene expression analyses reveal molecular relationships among 20 regions of the human CNS

  2006cited by this paper
• Effects of RNA degradation on gene expression analysis of human postmortem tissues

  2005cited by this paper
• Systemic lupus erythematosus disease activity index 2000.

  2002cited by this paper
• [Systemic lupus erythematosus].

  1955cited by this paper
• SYSTEMIC LUPUS ERYTHEMATOSUS: REVIEW OF THE LITERATURE AND CLINICAL ANALYSIS OF 138 CASES

  1954cited by this paper

• Machine Learning-Based Analysis of Serum Interleukin-39 and Interleukin-40 Levels for Differentiating Rheumatoid Arthritis and Systemic Lupus Erythematosus

  2025cites this paper
• Potential involvement of IL-40 in kidney disease associated to systemic lupus erythematosus

  2025cites this paper
• Comparative Investigation of Cardiac Injury Mediated by IL-40 and Oxidative Stress Markers in Pericardial Fluid and Serum

  2025cites this paper
• Serum Interleukin-40 and Soluble CD40 Ligand as Complementary Biomarkers for Disease Activity in Multiple Sclerosis Patients

  2025cites this paper
• Inhibition of Interleukin-40 prevents multi-organ damage during sepsis by blocking NETosis

  2025cites this paper
• Increased serum levels of IL-40 are associated with IgA and NETosis biomarkers in Covid-19 patients: IL-40 and infectious diseases

  2025cites this paper
• Serum IL-40 is elevated in systemic sclerosis and is linked to disease activity, gastrointestinal involvement, immune regulation and fibrotic processes

  2025cites this paper
• Serum IL-40 increases in patients with rheumatoid arthritis and correlates with some clinical characteristics and comorbidities

  2024cites this paper
• IL-41: A novel serum marker correlates with disease activity in patients with ankylosing spondylitis.

  2024cites this paper
• A Comprehensive Review on the Role of Interleukin-40 as a Biomarker for Diagnosing Inflammatory Diseases

  2024cites this paper